Cadrenal Therapeutics (CVKD) vs Alaunos Therapeutics (TCRT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($7.0 million vs $7.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVKD | TCRT |
|---|---|---|
| Share price | $1.70 | $1.66 |
| Market cap | $7.01M | $6.99M |
| 1-day change | +0.59% | +3.75% |
| EPS (TTM) | $-3.67 | $-1.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $5.00K |
| Revenue growth (YoY) | — | -50.00% |
| Net income (latest FY) | $-13.24M | $-4.18M |
| Operating margin | — | -84500.00% |
| Net margin | — | -83520.00% |
| 52-week high | $12.50 | $4.50 |
| 52-week low | $0.816 | $0.72 |
| Distance from 52-week high | -86.40% | -63.11% |
| Analyst consensus | none | — |
| Avg. price target upside | +723.53% | — |
| Average volume | 496.14K | 7.56M |
| Shares outstanding | 4.12M | 4.21M |
| Employees | 5 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
CVKD vs TCRT FAQ
Which is bigger, Cadrenal Therapeutics or Alaunos Therapeutics?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $7.01M compared with $6.99M for Alaunos Therapeutics (TCRT).
Are Cadrenal Therapeutics and Alaunos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.